SDTM-ETL

Sold by : XML4Pharma

What is SDTM-ETL?

SDTM-ETL is a software solution created by XML4Pharma. It simplifies the conversion of clinical data into the universally recognized CDISC SDTM format, guaranteeing adherence to industry standards. This tool expedites the submission of data for regulatory evaluation and enhances the overall data management process.

SDTM-ETL Pricing

To get a customized quote Click here >>

Company Details

Company Name : XML4Pharma
Visit Website
Contact Now

Key Features of SDTM-ETL

  • Graphical User Interface
  • Mapping Specification
  • Automated Mapping
  • Validation Rules
  • Data Transformation
  • Custom Functions
  • Metadata Management
  • Version Control
  • Audit Trail
  • Data Lineage
  • Error Handling
  • Performance Optimization
  • Integration With Cdisc Standards
  • Support For Multiple Data Sources
  • Scheduling And Automation
  • User Management
  • Role Based Access Control
  • Reporting And Analytics
  • Data Anonymization
  • Compliance With Regulatory Requirements
  • Show More

Specifications

Run On Mobile Browser : Yes
Available Support : Email,Phone
Languages Available : English
Talk To An Advisor
Contact Expert
SDTM-ETL Categories on SaasCounter

From Confused to Confident SDTM-ETL

Get expert assistance in your software evaluation journey

You agree to our Terms of Use and Privacy Policy.

Alternatives of SDTM-ETL

SDTM-ETL FAQ's

The top 5 features of SDTM-ETL include:

  • Graphical User Interface
  • Mapping Specification
  • Automated Mapping
  • Validation Rules
  • Data Transformation

SDTM-ETL supports a variety of platforms including: Email, Phone.

SDTM-ETL serves a wide range of businesses including StartUps, SMBs, Enterprises.

The top three competitors of SDTM-ETL are Pentaho IOT, CloverDX and Skyvia. To find the best fit for your business, compare and evaluate each platform's features, advantages, disadvantages, and other key aspects.

SDTM-ETL is available exclusively in English, providing a streamlined experience for English-speaking users.

Wait a moment, processing...